Devil's Claw
Harpagophytum procumbens
Description
overall appearance
A prostrate, perennial herb with creeping stems radiating up to 1.5 m from a central taproot system. The plant lies flat on the ground and is named for its distinctive woody fruit bearing multiple hooked, claw-like projections that entangle in animal fur for seed dispersal.
roots
Primary taproot descends to 50 cm, bearing secondary tuberous storage roots 15β25 cm long; these tubers are the primary medicinal part; flesh is whitish, bitter, and starchy
stem
Prostrate, spreading stems up to 1.5 m long, often reddish; covered with fine hairs; no erect stems
leaves
Opposite, petiolate, deeply 3β5 lobed, 3β8 cm long; gray-green; fleshy texture adapted to arid conditions; margins wavy to slightly dentate
flowers
Tubular-campanulate, deep pink to red-violet with yellow throat, 3β5 cm long; solitary in leaf axils; strikingly ornamental; blooms JanuaryβApril (southern hemisphere summer)
fruits/seeds
Highly distinctive woody capsule 10β15 cm across with numerous recurved, hook-like protrusions (the 'claws') up to 4 cm long; splits into segments, each carrying seeds
Active Compounds
Traditional Uses
- San and Khoikhoi traditional medicine (primary users): root decoctions for pain, fever, malaria, and digestive upset
- Bantu traditional medicine: poultices for sores, ulcers, boils, and skin lesions
- Traditional use for childbirth complications: root used to ease delivery and postpartum pain in southern Africa
- Fever and malaria treatment in traditional southern African medicine
- Treatment of diseases described as 'stiffness' β likely rheumatic and arthritic conditions
- Digestive bitters: root preparations used for loss of appetite and liver/gallbladder complaints
- Introduced to Europe in 1950s by G.H. Mehnert and commercialized by 1970s for arthritis
Modern Applications
- Osteoarthritis: 8 RCTs and multiple meta-analyses demonstrate efficacy comparable to diacerhein for knee and hip OA (harpagoside 50β100 mg/day)
- Low back pain: Cochrane review (2004, updated 2014) supports superiority to placebo for non-specific LBP
- Anti-inflammatory: harpagoside inhibits COX-2, TNF-Ξ±, iNOS, and NF-ΞΊB signaling in macrophage models
- Analgesic: central and peripheral pain pathways modulated in rodent studies
- Tendinopathy and muscle pain: sports medicine applications for DOMS and repetitive strain injuries
- Uric acid excretion: mild uricosuric effect supports use in gout
- Liver and gallbladder support: bitter glycosides stimulate bile flow
- Heart rate reduction: harpagoside shows negative chronotropic effect in isolated heart preparations
β οΈ Safety Information
Contraindications
- Peptic ulcer disease and gastroesophageal reflux: bitter glycosides stimulate gastric acid secretion
- Gallstones: choleretic effect can trigger biliary colic
- Pregnancy: uterine-stimulating activity; contraindicated throughout
- Cardiac arrhythmia (pre-existing): negative chronotropic effects at high doses
- Children under 12: no safety data
Side Effects
- Diarrhea and loose stools (most common, 8β12% of users in trials)
- Nausea, abdominal pain, and loss of appetite
- Allergic reactions: skin rash and urticaria (rare, ~1%)
- Mild hypoglycemia reported in one case series at high doses
Drug Interactions
- Warfarin and anticoagulants: case reports of elevated INR; monitor closely
- Antidiabetic agents (insulin, metformin): possible additive hypoglycemic effect
- Antiarrhythmic drugs (digoxin, amiodarone): negative chronotropic effects may be additive
- NSAIDs and analgesics: potentially additive anti-inflammatory effects; beneficial combination but monitor for GI effects
Parts Used
- Secondary storage roots (tubers) β primary medicinal part
- Primary root (less medicinal value, lower iridoid content)
- Leaves and stems (minor traditional use)
Preparation Methods
Standardized dry extract (standardized to harpagoside): 600β1,200 mg three times daily (2.0β2.6% harpagoside = 50β100 mg harpagoside/day)
WS 1531 extract (proprietary aqueous preparation): 800 mg twice daily (most RCT-studied form)
Crude dried root decoction: 4.5 g root in 300 mL water, simmered 20 minutes, taken in divided doses
Tincture (1:5 in 25% ethanol): 1β2 mL three times daily with meals
Capsules of root powder: 500β750 mg three times daily
Topical gel (1% harpagoside equivalent): applied to affected joints 3Γ daily
Related Plants
Buchu
Agathosma betulina
Andrographis
Andrographis paniculata
Bitter Melon
Momordica charantia
Guduchi / Giloy
Tinospora cordifolia
Haritaki / Black Myrobalan (Triphala representative)
Terminalia chebula
Hoodia
Hoodia gordonii